ACCREDO Trademark

Trademark Overview


On Friday, January 4, 2008, a trademark application was filed for ACCREDO with the United States Patent and Trademark Office. The USPTO has given the ACCREDO trademark a serial number of 77364413. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, September 24, 2019. This trademark is owned by Accredo Health Group, Inc.. The ACCREDO trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing patient educational services, namely, conducting programs in the field of chronic disease, proper product-reconstitution and administration, and resources appropriate for support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, namely, conducting workshops for children to help them to understand hemophilia; educational services, namely, conducting workshops for children to help them understand hemophilia

Retail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia

Nursing care specializing in the treatment and control of chronic diseases; nursing care specializing in the treatment and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counseling, namely, offering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical services, namely, specialized pharmaceutical advice for individuals with bleeding disorders

Providing clinical research in the field of medicine for product manufacturers, pharmaceutical and biotech companies, contract research organizations and insurance providers, and providing consulting services in support of new drug product launches
accredo

General Information


Serial Number77364413
Word MarkACCREDO
Filing DateFriday, January 4, 2008
Status800 - REGISTERED AND RENEWED
Status DateTuesday, September 24, 2019
Registration Number3667385
Registration DateTuesday, August 11, 2009
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 26, 2008

Trademark Statements


Goods and ServicesProviding patient educational services, namely, conducting programs in the field of chronic disease, proper product-reconstitution and administration, and resources appropriate for support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, namely, conducting workshops for children to help them to understand hemophilia; educational services, namely, conducting workshops for children to help them understand hemophilia
Description of MarkThe mark consists of the stylized literal element.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesRetail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia
Goods and ServicesNursing care specializing in the treatment and control of chronic diseases; nursing care specializing in the treatment and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counseling, namely, offering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical services, namely, specialized pharmaceutical advice for individuals with bleeding disorders
Goods and ServicesProviding clinical research in the field of medicine for product manufacturers, pharmaceutical and biotech companies, contract research organizations and insurance providers, and providing consulting services in support of new drug product launches

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, January 8, 2008
Primary Code035
First Use Anywhere DateSaturday, October 18, 2008
First Use In Commerce DateSaturday, October 18, 2008

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, January 8, 2008
Primary Code041
First Use Anywhere DateSaturday, October 18, 2008
First Use In Commerce DateSaturday, October 18, 2008

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 8, 2008
Primary Code042
First Use Anywhere DateFriday, June 13, 2008
First Use In Commerce DateFriday, June 13, 2008

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 8, 2008
Primary Code044
First Use Anywhere DateSaturday, October 18, 2008
First Use In Commerce DateSaturday, October 18, 2008

Trademark Owner History


Party NameEXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressST. LOUIS, MO 63121

Party NameAccredo Health Group, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMemphis, TN 38134

Party NameAccredo Health Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMemphis, TN 38134

Party NameAccredo Health Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMemphis, TN 38134

Trademark Events


Event DateEvent Description
Monday, March 24, 2008ASSIGNED TO EXAMINER
Monday, July 21, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 8, 2008NEW APPLICATION ENTERED
Monday, March 24, 2008NON-FINAL ACTION WRITTEN
Monday, March 24, 2008NON-FINAL ACTION E-MAILED
Monday, March 24, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 21, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2008ASSIGNED TO LIE
Tuesday, July 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 13, 2009TEAS STATEMENT OF USE RECEIVED
Wednesday, May 13, 2009USE AMENDMENT FILED
Wednesday, July 23, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 24, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 6, 2008NOTICE OF PUBLICATION
Tuesday, August 26, 2008PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2009STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 16, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 16, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, September 5, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, June 2, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 6, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 6, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, August 11, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, August 6, 2015TEAS SECTION 8 & 15 RECEIVED
Saturday, September 5, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 3, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, September 5, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, August 11, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 12, 2019TEAS SECTION 8 & 9 RECEIVED
Monday, August 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 20, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 24, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, September 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 24, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED